ZYNRELEF
ZYNRELEF
Discontinued
DIN Number
02526034
Drug Class
Human
Market Date
N/A
Company
HC
Heron Therapeutics, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02526034
AIG Number0263461002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N01BB59 BUPIVACAINE AND MELOXICAM
Product Specifications
Dosage FormSolution (Extended Release)
Route of AdministrationInstillation
AHFS Classification72:00.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
BUPIVACAINEActive
Strength: 400 MG / 14 ML
Monograph: BUPIVACAINE
MELOXICAMActive
Strength: 12 MG / 14 ML
Monograph: MELOXICAM